1. Home
  2. OZ vs ANTX Comparison

OZ vs ANTX Comparison

Compare OZ & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belpointe PREP LLC Units

OZ

Belpointe PREP LLC Units

N/A

Current Price

$36.65

Market Cap

194.7M

Sector

N/A

ML Signal

N/A

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$3.56

Market Cap

172.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OZ
ANTX
Founded
2020
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
194.7M
172.9M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
OZ
ANTX
Price
$36.65
$3.56
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $9.00
AVG Volume (30 Days)
27.7K
★ 295.2K
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.56
EPS
N/A
★ N/A
Revenue
★ $9,187,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 243.44
N/A
52 Week Low
$35.42
$1.00
52 Week High
$69.00
$7.19

Technical Indicators

Market Signals
Indicator
OZ
ANTX
Relative Strength Index (RSI) 26.43 29.98
Support Level $35.42 $2.87
Resistance Level $48.00 $5.15
Average True Range (ATR) 1.40 0.33
MACD 0.02 -0.05
Stochastic Oscillator 13.78 14.64

Price Performance

Historical Comparison
OZ
ANTX

About OZ Belpointe PREP LLC Units

Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset. The majority of the revenue is earn from mixed-use segment.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: